Literature DB >> 17397444

Alzheimer's disease medication: use and cost projections for Medicare Part D.

Nancy E Morden, Judy T Zerzan, Eric B Larson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17397444     DOI： 10.1111/j.1532-5415.2007.01106.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  3 in total

1.  Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity?

Authors:  Kenneth M Langa; Eric B Larson; Jason H Karlawish; David M Cutler; Mohammed U Kabeto; Scott Y Kim; Allison B Rosen
Journal:  Alzheimers Dement       Date:  2008-03-04       Impact factor: 21.566

2.  Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials.

Authors:  Dae Hyun Kim; Rebecca T Brown; Eric L Ding; Douglas P Kiel; Sarah D Berry
Journal:  J Am Geriatr Soc       Date:  2011-06-07       Impact factor: 5.562

3.  The timing of drug funding announcements relative to elections: a case study involving dementia medications.

Authors:  Sudeep S Gill; Neeraj Gupta; Chaim M Bell; Paula A Rochon; Peter C Austin; Andreas Laupacis
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.